Proliferation and hypoxia in human squamous cell carcinoma of the cervix: First report of combined immunohistochemical assays

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 4, 1997, Pages 897-905

  Kennedy, Andrew S ^a   Raleigh, James A ^a   Perez, Gerardo M ^a   Calkins, Dennise P ^a   Thrall, Donald E ^a   Novotny, Debra B ^b   Varia, Mahesh A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Cervix carcinoma; Hypoxia; Hypoxia marker; MIB 1; PCNA; Pimonidazole; Proliferation

Indexed keywords

CELL MARKER; CYCLINE; MONOCLONAL ANTIBODY KI 67; PIMONIDAZOLE;

ARTICLE; BINDING AFFINITY; CELL HYPOXIA; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

ADULT; ANTIGENS, NUCLEAR; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL HYPOXIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; NITROIMIDAZOLES; NUCLEAR PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; RADIATION-SENSITIZING AGENTS; UTERINE CERVICAL NEOPLASMS;

EID: 0030995145     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00539-1     Document Type: Article

References (45)

1. Arteel, G. E.; Thurman, R. G.; Yates, J. M.; Raleigh, J. A. Evidence that hypoxia markers detect oxygen gradients in liver: Pimonidazole and retrograde perfusion of rat liver. Br. J. Cancer 72:889-895; 1995.
2. Begg, A. C. The clinical status of Tpot as a predictor? Or why no tempest in the Tpot! Int. J. Radiat. Oncol. Biol. Phys. 32:1539-1540; 1995.
3. Brock, W. A.; Baker, F. L.; Wike, J. L.; Sivon, S. L.; Peters, L. J. Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumor control. Int. J. Radiat. Oncol. Biol. Phys. 18:1283-1286; 1990.
4. Chaplin, D. J. The effect of therapy on tumour vascular function. Int. J. Radiat. Biol. 60:311-325; 1991.
5. Chaplin, D. J.; Horsman, M. R. Tumor blood flow changes induced by chemical modifiers of radiation response. Int. J. Radiat. Oncol. Biol. Phys. 22:459-462; 1992.
6. Chapman, J. D.; Baer, K.; Lee, J. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. Cancer Res. 43:1523-1528; 1983.
7. Cline, J. M.; Thrall, D. E.; Page, R. L.; Franko, A. J.; Raleigh, J. A. Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours. Br. J. Cancer 62:925-931; 1990.
8. Cline, J. M.; Thrall, D. E.; Rosner, G. L.; Raleigh, J. A. Distribution of the hypoxia marker CC1-103F in canine tumors. Int. J. Radiat. Oncol. Biol. Phys. 28:921-933; 1994.
9. Cobb, L. M.; Nolan, J.; Butler, S. A. Distribution of pimonidazole and RSU 1069 in tumour and normal tissues. Br. J. Cancer 62:915-915; 1990.
10. Cobb, L. M.; Nolan, J.; Hacker, T. Retention of misonidazole in normal and malignant tissues: Interplay of hypoxia and reductases. Int. J. Radiat. Oncol. Biol. Phys. 22:655-659; 1992.
11. Cole, D. J.; Brown, D. C.; Crossley, E.; Alcock, C. J.; Gatter, K. C. Carcinoma of the cervix uteri: An assessment of the relationship of tumour proliferation to prognosis. Br. J. Cancer 65:783-785; 1992.
12. Dennis, M. F.; Stratford, M. R.; Wardman, P.; Watts, M. E. Cellular uptake of misonidazole and analogues with acidic or basic functions. Int. J. Radiat. Biol. 47:629-643; 1985.
13. Dische, S.; Machin, D.; Chassange, D. A trial of Ro 03-8799 (pimonidazole) in carcinoma of the uterine cervix: An interim report from the Medical Research Council Working Party on advanced carcinoma of the cervix. Radiother. Oncol. 26:93-103; 1993.
14. Evans, S. M.; Joiner, B.; Jenkins, W. T.; Laughlin, K. M.; Lord, E. M.; Koch, C. J. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-l-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]. Br. J. Cancer 72:875-882; 1995.
15. Franko, A. J. Hypoxic fraction and binding of misonidazole in EMT6/Ed multicellular tumor spheroids. Radiat. Res. 103:89-97; 1985.
16. Franko, A. J.; Koch, C. J.; Garrecht, B. M.; Sharplin, J.; Hughes, D. Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro. Cancer Res. 47:5367-5376; 1987.
17. Gatenby, R.; Kessler, H.; Rosenblum, J.; Cola, L.; Moldovsky, P.; Hartz, W.; Broder, G. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 14:831-838; 1988.
18. Giaccia, A. J. Hypoxic stress proteins: Survival of the fittest. Semin. Radiat. Oncol. 6:46-58; 1996.
19. Graeber, T. G.; Peterson, J. F.; Tsai, M.; Monica, K.; Fornace, A. J. J.; Giaccia, A. J. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14:6264-6277; 1994.
20. Gross, M. W.; Karbach, U.; Groebe, K.; Franko, A. J.; Mueller-Klieser, W. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids. Int. J. Cancer 61:567-573; 1995.
21. Hepburn, P. J.; Glynne-Jones, E.; Goddard, L.; Gee, J. M.; Harper, M. E. Cell proliferation in prostatic carcinoma: Comparative analysis of Ki-67, MIB-1 and PCNA. Histochem. J. 27:196-203; 1995.
22. Höckel, M.; Schlenger, K.; Mitze, M.; Schaffer, U.; Vaupel, P. Hypoxia and radiation response in human tumors. Semin. Radiat. Oncol. 6:3-9; 1996.
23. Hodgkiss, R. J.; Wardman, P. The measurement of hypoxia in tumours. Br. J. Radiol. Suppl. 24:105-110; 1992.
24. Key, G.; Becker, M. H.; Duchrow, M.; Schlüter, C.; Flad, H. D.; Gerdes, J. New Ki-67 equivalent murine monoclonal antibodies (MIB1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab. Invest. 68:629-636; 1993.
25. 14C-misonidazole to hypoxic cells: Kinetic dependence on oxygen concentration and misonidazole concentration. Int. J. Radiat. Oncol. Biol. Phys. 10:1327-1331; 1984.
26. Martin, G. R.; Jain, R. K. Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy. Cancer Res. 54:5670-5674; 1994.
27. Miller, G.; Best, M.; Franko, A.; Koch, C.; Raleigh, J. Quantitation of hypoxia in multicellular spheroids by video image analysis. Int. J. Radiat. Oncol. Biol. Phys. 16:949-952; 1989.
28. Murray, J. C.; Randhawa, V.; Denekamp, J. The effects of melphalan and misonidazole on the vasculature of a murine sarcoma. Br. J. Cancer 55:233-238; 1987.
29. Nakano, T.; Oka, K. Differential values of Ki-67 index and mitotic index of proliferation cell population. Cancer 72:2401-2408; 1993.
30. Raleigh, J. A.; Dewhirst, M. W.; Thrall, D. E. Measuring tumor hypoxia. Semin. Radiat. Oncol. 6:37-45; 1996.
31. Raleigh, J. A.; La Dine, J. K.; Cline, J. M.; Thrall, D. E. An enzyme-linked immunosorbent assay for hypoxia marker binding in tumours. Br. J. Cancer 69:66-71; 1994.
32. Raleigh, J. A.; Miller, G. G.; Franko, A. J.; Koch, C. J.; Fuciarelli, A. F.; Kelly, D. A. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. Br. J. Cancer 56:395-400; 1987.
33. Raleigh, J. A.; Zeman, E. M.; Calkins, D. P.; McEntee, M. C.; Thrall, D. E. Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors. Acta Oncol. 34:345-349; 1995.
34. Saunders, M. I.; Anderson, P. J.; Bennett, M. H.; Dische, S.; Minchinton, A. I.; Stratford, M. R. L. The clinical testing of Ro 03-8799 - Pharmacokinetics, toxicology, tissue and tumor concentrations. Int. J. Radiat. Oncol. Biol. Phys. 10:1759-1763; 1984.
35. Sutherland, R. M.; Ausserer, W. A.; Murphy, B. J.; Laderoute, K. R. Tumor hypoxia and heterogeneity: Challenges and opportunities for the future. Semin. Radiat. Oncol. 6:59-70; 1996.
36. Taghian, A.; Ramsay, J.; Allalunis-Turner, J.; Budach, W.; Gioioso, D.; Pardo, F.; Okunieff, P.; Bleehen, N.; Urtasun, R.; Suit, H. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int. J. Radial. Oncol. Biol. Phys. 25:243-249; 1993.
37. Theon, A. P.; Madewell, B. R.; Shearn, V. J.; Moulton, J. E. Prognostic factors associated with radiotherapy of squamous cell carcinoma of the nasal plane in cats. J. Am. Vet. Med. Assoc. 206:991-996; 1995.
38. Thrall, D. E.; McEntee, M. C.; Cline, J. M.; Raleigh, J. A. ELISA quantification of CCI-103F binding in canine tumors prior to and during irradiation. Int. J. Radiat. Oncol. Biol. Phys. 28:649-659; 1994.
39. West, C. M.; Davidson, S. E.; Burt, P. A.; Hunter, R. D. The intrinsic radiosensitivity of cervical carcinoma: Correlations with clinical data. Int. J. Radiat. Oncol. Biol. Phys. 31:841-846; 1995.
40. West, C. M.; Davidson, S. E.; Roberts, S. A.; Hunter, R. D. Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br. J. Cancer 68:819-823; 1993.
41. Wike-Hooley, J. L.; Haveman, J.; Reinhold, H. S. The relevance of tumour pH to the treatment of malignant disease. Radiother. Oncol. 2:343-366; 1984.
42. Willett, C. G.; Warland, G.; Hagan, M. P.; Daly, W. J.; Coen, J.; Shellito, P. C.; Compton, C. C. Tumor proliferation in rectal cancer following preoperative irradiation. J. Clin. Oncol. 13:1417-1424; 1995.
43. Wilson, R. E.; Sutherland, R. M. Enhanced synthesis of specific proteins, RNA, and DNA caused by hypoxia and reoxygenation. Int. J. Radiat. Oncol. Biol. Phys. 16:957-961; 1989.
44. Yu, C.; Filipe, M. I. Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications. Histochem. J. 25:843-853; 1993.
45. Zeman, E. M.; Calkins, D. P.; Cline, J. M.; Thrall, D. E.; Raleigh, J. A. The relationship between proliferative and oxygenation status in spontaneous canine tumors. Int. J. Radiat. Oncol. Biol. Phys. 27:891-898; 1993.